ALKERAN Side Effects

6616024-X | Blood Bilirubin Unconjugated Increased, Haptoglobin Decreased, Hepatitis A Antibody Positive
on Feb 22, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with myelodysplastic syndrome and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin unconjugated increased, haptoglobin decreased, hepatitis a antibody positive. Alkeran dosage: 80mg Per Day. During the same period patient was treated with FLUDARA (View Fludara Review and Fludara Label ).

6616023-8 | Blood Bilirubin Unconjugated Increased, Hepatitis A Antibody Positive
Patient was taking Alkeran (View Usage). Patient had the following side effects: blood bilirubin unconjugated increased, hepatitis a antibody positive on Feb 22, 2010 from JAPAN Additional patient health information: Female patient , 58 years of age, was diagnosed with diffuse large b-cell lymphoma and. Alkeran dosage: 80mg Per Day. During the same period patient was treated with FLUDARA (100mg Per Day) (View Fludara Review and Fludara Label ).

6604894-0 | Syncope
Adverse event was reported on Feb 18, 2010 by a Female patient taking Alkeran (View Usage) (Dosage: 2mg Per Day) . Location: JAPAN , 73 years of age, After Alkeran was administered, patient had the following side effects: syncope. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), GASTER (View Gaster Review and Gaster Label ).

6604891-5 | Syncope
on Feb 18, 2010 Male patient from JAPAN , 73 years of age, was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: syncope. Alkeran dosage: 2mg Per Day. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), GASTER (View Gaster Review and Gaster Label ).


6603294-7 | Nausea
on Feb 13, 2009 Female patient from UNITED STATES , 88 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). Patient had the following side effects: nausea (What is nausea?). Alkeran dosage: 14mg Single Dose. During the same period patient was treated with THALIDOMIDE (100mg Single Dose) (View Thalidomide Review and Thalidomide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ALPRAZOLAM (1mg At Night) (View Alprazolam Review and Alprazolam Label ), ARICEPT (5mg Per Day) (View Aricept Review and Aricept Label ), CALCIUM (View Calcium Review and Calcium Label ), DARVOCET (1tab Four Times Per Day) (View Darvocet Review and Darvocet Label ), LOTREL (View Lotrel Review and Lotrel Label ), NEXIUM (40mg Twice Per Day) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6603293-5 | Bone Pain, Paraesthesia, White Blood Cell Count Decreased
Patient was taking Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: bone pain, paraesthesia, white blood cell count decreased on Jan 28, 2009 from UNITED STATES Additional patient health information: Male patient , 79 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Alkeran dosage: . During the same period patient was treated with THALIDOMIDE (100mg Per Day) (View Thalidomide Review and Thalidomide Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), REVLIMID (View Revlimid Review and Revlimid Label ).

6603292-3 | Bone Pain, Condition Aggravated, Constipation, Feeling Abnormal, Muscle Spasms, Neuralgia, Neuropathy Peripheral, Sciatica
Adverse event was reported on Jan 05, 2009 by a Male patient taking Alkeran (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 75 years of age, weighting 155.4 lb, Patient experienced the following unwanted or unexpected effects: bone pain, condition aggravated, constipation (What is constipation?), feeling abnormal, muscle spasms, neuralgia, neuropathy peripheral, sciatica (What is sciatica?). During the same period patient was treated with THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), XALATAN (View Xalatan Review and Xalatan Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), OXAZOLAM (View Oxazolam Review and Oxazolam Label ).

6600200-6 | Decreased Appetite, Febrile Neutropenia, Herpes Zoster, Nausea, Neutrophil Count Decreased
on Feb 15, 2010 Male patient from JAPAN , 78 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Alkeran (View Usage). Patient had the following side effects: decreased appetite, febrile neutropenia, herpes zoster, nausea (What is nausea?), neutrophil count decreased. Alkeran dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), ANTIMICROBIAL (View Antimicrobial Review and Antimicrobial Label ).

6600198-0 | Blood Lactate Dehydrogenase Increased, Brain Stem Infarction, Platelet Count Decreased, Renal Failure Acute, Thrombotic Thrombocytopenic Purpura
on Feb 15, 2010 Female patient from JAPAN , 69 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: blood lactate dehydrogenase increased, brain stem infarction, platelet count decreased, renal failure acute, thrombotic thrombocytopenic purpura. Alkeran dosage: . During the same period patient was treated with RANIMUSTINE (View Ranimustine Review and Ranimustine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6585441-9 | Syncope
Patient was taking Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: syncope on Feb 10, 2010 from JAPAN Additional patient health information: Female patient , 73 years of age, . Alkeran dosage: 2mg Per Day. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), GASTER (View Gaster Review and Gaster Label ).

6576911-8 | Altered State Of Consciousness, Dizziness, Dyspnoea
Adverse event was reported on Feb 04, 2010 by a Male patient taking Alkeran (View Usage) (Dosage: ) . Location: JAPAN , 65 years of age, Patient had the following side effects: altered state of consciousness, dizziness (What is dizziness?), dyspnoea. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ).

6570710-9 | Anaemia, Asthenia, Diarrhoea, Dyspepsia, Nausea, Neutropenia, Respiratory Disorder, Weight Decreased
on Jan 26, 2010 Female patient from FRANCE , weighting 156.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis, glaucoma (What is glaucoma?) and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: anaemia, asthenia, diarrhoea, dyspepsia, nausea (What is nausea?), neutropenia, respiratory disorder, weight decreased. Alkeran dosage: 18mg Per Day. During the same period patient was treated with THALIDOMIDE (200mg Per Day) (View Thalidomide Review and Thalidomide Label ), PREDNISONE (140mg Per Day) (View Prednisone Review and Prednisone Label ), ARIXTRA (7.5mg Per Day) (View Arixtra Review and Arixtra Label ), BEFIZAL (400mg Per Day) (View Befizal Review and Befizal Label ), DAFALGAN (4g Per Day) (View Dafalgan Review and Dafalgan Label ), ABUFENE (800mg Twice Per Day) (View Abufene Review and Abufene Label ), AERIUS (5mg Per Day) (View Aerius Review and Aerius Label ), NEXIUM (20mg Per Day) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6566825-1 | Multiple Myeloma
on Jan 27, 2010 Male patient from UNITED STATES , 80 years of age, was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: multiple myeloma (What is multiple myeloma?). Alkeran dosage: .

6550527-1 | Leukoencephalopathy
Patient was taking Alkeran (View Usage). Patient had the following side effects: leukoencephalopathy on Jan 19, 2010 from JAPAN Additional patient health information: Female patient , child 3 years of age, . Alkeran dosage: 50mg Per Day. During the same period patient was treated with THIOTEPA (View Thiotepa Review and Thiotepa Label ).

6543520-6 | Leukoencephalopathy
Adverse event was reported on Jan 15, 2010 by a Female patient taking Alkeran (View Usage) (Dosage: 50mg Per Day) . Location: JAPAN , child 3 years of age, After Alkeran was administered, patient had the following side effects: leukoencephalopathy.

6543498-5 | Anaphylactic Reaction, Convulsion, Mucous Membrane Disorder, Shock
on Jan 15, 2010 Male patient from JAPAN , child 3 years of age, was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, convulsion, mucous membrane disorder, shock. Alkeran dosage: . Patient was hospitalized.

6542241-3 | Convulsion
on Jan 14, 2010 Male patient from JAPAN , 61 years of age, was treated with Alkeran (View Usage). Patient had the following side effects: convulsion. Alkeran dosage: .

6537661-7 | Engraftment Syndrome, Febrile Neutropenia, Respiratory Failure
Patient was taking Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: engraftment syndrome, febrile neutropenia, respiratory failure on Jan 13, 2010 from JAPAN Additional patient health information: Female patient , weighting 90.39 lb, was diagnosed with stem cell transplant and. Alkeran dosage: 140mg Per Day. During the same period patient was treated with GRAN (View Gran Review and Gran Label ), NASEA (View Nasea Review and Nasea Label ), FLUCONAL (View Fluconal Review and Fluconal Label ), PYDOXAL (View Pydoxal Review and Pydoxal Label ), BAKTAR (View Baktar Review and Baktar Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), CRAVIT (View Cravit Review and Cravit Label ), CALTAN (View Caltan Review and Caltan Label ). Patient was hospitalized.

6534624-2 | Engraftment Syndrome, Febrile Neutropenia, Respiratory Failure
Adverse event was reported on Jan 06, 2010 by a Female patient taking Alkeran (View Usage) (Dosage: 140mg Per Day) was diagnosed with stem cell transplant and. Location: JAPAN , weighting 90.39 lb, Patient experienced the following unwanted or unexpected effects: engraftment syndrome, febrile neutropenia, respiratory failure. During the same period patient was treated with GRAN (View Gran Review and Gran Label ), NASEA (View Nasea Review and Nasea Label ), FLUCONAL (View Fluconal Review and Fluconal Label ), PYDOXAL (View Pydoxal Review and Pydoxal Label ), BAKTAR (View Baktar Review and Baktar Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), CRAVIT (View Cravit Review and Cravit Label ), CALTAN (View Caltan Review and Caltan Label ). Patient was hospitalized.

6507857-9 | Bone Marrow Failure, Decreased Appetite, Fatigue, Increased Upper Airway Secretion, Iron Overload, White Blood Cell Count Decreased
on Dec 14, 2009 Male patient from UNITED STATES , 75 years of age, was treated with Alkeran (View Usage). Patient had the following side effects: bone marrow failure, decreased appetite, fatigue, increased upper airway secretion, iron overload, white blood cell count decreased. Alkeran dosage: 6mg Per Day. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), POTASSIUM (View Potassium Review and Potassium Label ), PAXIL (View Paxil Review and Paxil Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CIPRO (View Cipro Review and Cipro Label ). Patient was hospitalized.

6493690-3 | Anaphylactic Reaction, Convulsion, Mucous Membrane Disorder, Shock
on Dec 09, 2009 Female patient from JAPAN , child 3 years of age, was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: anaphylactic reaction, convulsion, mucous membrane disorder, shock. Alkeran dosage: .

6477978-8 | Asthenia, Diarrhoea, Dyspepsia, Nausea, Neutropenia, Respiratory Disorder, Weight Decreased
Patient was taking Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, diarrhoea, dyspepsia, nausea (What is nausea?), neutropenia, respiratory disorder, weight decreased on Nov 25, 2009 from FRANCE Additional patient health information: Female patient , weighting 156.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis, glaucoma (What is glaucoma?) and. Alkeran dosage: 18mg Per Day. During the same period patient was treated with THALIDOMIDE (200mg Per Day) (View Thalidomide Review and Thalidomide Label ), PREDNISONE (140mg Per Day) (View Prednisone Review and Prednisone Label ), ARIXTRA (7.5mg Per Day) (View Arixtra Review and Arixtra Label ), BEFIZAL (400mg Per Day) (View Befizal Review and Befizal Label ), DAFALGAN (4g Per Day) (View Dafalgan Review and Dafalgan Label ), ABUFENE (800mg Twice Per Day) (View Abufene Review and Abufene Label ), AERIUS (5mg Per Day) (View Aerius Review and Aerius Label ), NEXIUM (20mg Per Day) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6461054-4 | Asthenia, Diarrhoea, Dyspepsia, Nausea, Neutropenia, Respiratory Disorder, Weight Decreased
Adverse event was reported on Nov 19, 2009 by a Female patient taking Alkeran (View Usage) (Dosage: 18mg Per Day) was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis, glaucoma (What is glaucoma?) and. Location: FRANCE , weighting 156.5 lb, Patient had the following side effects: asthenia, diarrhoea, dyspepsia, nausea (What is nausea?), neutropenia, respiratory disorder, weight decreased. During the same period patient was treated with THALIDOMIDE (200mg Per Day) (View Thalidomide Review and Thalidomide Label ), PREDNISONE (140mg Per Day) (View Prednisone Review and Prednisone Label ), ARIXTRA (7.5mg Per Day) (View Arixtra Review and Arixtra Label ), BEFIZAL (400mg Per Day) (View Befizal Review and Befizal Label ), DAFALGAN (4g Per Day) (View Dafalgan Review and Dafalgan Label ), ABUFENE (800mg Twice Per Day) (View Abufene Review and Abufene Label ), AERIUS (5mg Per Day) (View Aerius Review and Aerius Label ), NEXIUM (20mg Per Day) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6450996-1 | Deep Vein Thrombosis
on Nov 13, 2009 Female patient from FRANCE , 76 years of age, was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?). Alkeran dosage: 4mg Per Day. During the same period patient was treated with THALIDOMIDE (100mg Per Day) (View Thalidomide Review and Thalidomide Label ), SOLUPRED (60mg Per Day) (View Solupred Review and Solupred Label ). Patient was hospitalized.

6443143-3 | Back Pain, Febrile Neutropenia, Pancytopenia
on Oct 27, 2009 Male patient from UNITED STATES , 86 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), febrile neutropenia, pancytopenia. Alkeran dosage: . During the same period patient was treated with REVLIMID (10mg Per Day) (View Revlimid Review and Revlimid Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PROCRIT (View Procrit Review and Procrit Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

6428472-1 | Asthenia, Dyspepsia
Patient was taking Alkeran (View Usage). Patient had the following side effects: asthenia, dyspepsia on Oct 30, 2009 from FRANCE Additional patient health information: Female patient , weighting 156.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), bone pain, thrombosis and. Alkeran dosage: 18mg Per Day. During the same period patient was treated with THALIDOMIDE (200mg Per Day) (View Thalidomide Review and Thalidomide Label ), PREDNISONE TAB (140mg Per Day) (View Prednisone Tab Review and Prednisone Tab Label ), OXYCONTIN (20mg Per Day) (View Oxycontin Review and Oxycontin Label ), ARIXTRA (View Arixtra Review and Arixtra Label ), BEFIZAL (400mg Per Day) (View Befizal Review and Befizal Label ), DAFALGAN (4g Per Day) (View Dafalgan Review and Dafalgan Label ), ABUFENE (400mg Per Day) (View Abufene Review and Abufene Label ), AERIUS (5mg Per Day) (View Aerius Review and Aerius Label ). Patient was hospitalized.

6398489-4 | Chronic Myelomonocytic Leukaemia
Adverse event was reported on Oct 05, 2009 by a Female patient taking Alkeran (View Usage) (Dosage: ) . Location: JAPAN , 77 years of age, After Alkeran was administered, patient had the following side effects: chronic myelomonocytic leukaemia. Patient was hospitalized.

6336486-5 | Bone Marrow Failure, Chills, Diarrhoea, Productive Cough, Pyrexia, Stem Cell Transplant, Toxic Skin Eruption
on Aug 25, 2009 Female patient from FRANCE , weighting 167.6 lb, was diagnosed with diffuse large b-cell lymphoma, antibiotic prophylaxis and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, chills, diarrhoea, productive cough, pyrexia, stem cell transplant, toxic skin eruption. Alkeran dosage: 267.4mg Single Dose. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), MABTHERA (View Mabthera Review and Mabthera Label ), NOVANTRONE (View Novantrone Review and Novantrone Label ), HOLOXAN (View Holoxan Review and Holoxan Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), BICNU (573mg Single Dose) (View Bicnu Review and Bicnu Label ), ARACYTINE (191mg Twice Per Day) (View Aracytine Review and Aracytine Label ), VANCOCIN HYDROCHLORIDE (View Vancocin Hydrochloride Review and Vancocin Hydrochloride Label ). Patient was hospitalized.

6332792-9 | Blood Amylase Increased, Salivary Gland Pain
on Aug 21, 2009 Male patient from JAPAN , 56 years of age, was treated with Alkeran (View Usage). Patient had the following side effects: blood amylase increased, salivary gland pain. Alkeran dosage: .

6331036-1 | Multiple Myeloma
Patient was taking Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: multiple myeloma (What is multiple myeloma?) on Aug 19, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Alkeran dosage: . During the same period patient was treated with THALIDOMIDE (100mg Per Day) (View Thalidomide Review and Thalidomide Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), VELCADE (View Velcade Review and Velcade Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LASIX (View Lasix Review and Lasix Label ), FLOMAX (View Flomax Review and Flomax Label ), INSULIN (View Insulin Review and Insulin Label ), MAXZIDE (View Maxzide Review and Maxzide Label ).

6318195-1 | Bone Marrow Failure, Chills, Productive Cough, Pyrexia, Toxic Skin Eruption
Adverse event was reported on Aug 13, 2009 by a Female patient taking Alkeran (View Usage) (Dosage: 267.4mg Single Dose) was diagnosed with diffuse large b-cell lymphoma, antibiotic prophylaxis and. Location: FRANCE , weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: bone marrow failure, chills, productive cough, pyrexia, toxic skin eruption. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), MABTHERA (View Mabthera Review and Mabthera Label ), MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), HOLOXAN (View Holoxan Review and Holoxan Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), BICNU (573mg Single Dose) (View Bicnu Review and Bicnu Label ), ARACYTINE (191mg Twice Per Day) (View Aracytine Review and Aracytine Label ), VEPESID (191mg Twice Per Day) (View Vepesid Review and Vepesid Label ). Patient was hospitalized.

6314984-8 | Abdominal Distension, Amoebic Colitis, Blood Urea Increased, C-reactive Protein Increased, Colonic Stenosis, Constipation, Diarrhoea, Femoral Artery Occlusion, Fistula
on Aug 10, 2009 Male patient from JAPAN , 64 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). Patient had the following side effects: abdominal distension, amoebic colitis, blood urea increased, c-reactive protein increased, colonic stenosis, constipation (What is constipation?), diarrhoea, femoral artery occlusion, fistula (What is fistula?). Alkeran dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6302962-4 | Abdominal Distension, Amoebic Colitis, Colonic Stenosis, Constipation, Diarrhoea, Femoral Artery Occlusion, Fistula, Haematochezia, Immunosuppression
on Aug 03, 2009 Male patient from JAPAN , 64 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: abdominal distension, amoebic colitis, colonic stenosis, constipation (What is constipation?), diarrhoea, femoral artery occlusion, fistula (What is fistula?), haematochezia, immunosuppression. Alkeran dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6286480-8 | Fungal Infection, Haematotoxicity, Infection Susceptibility Increased, Leukopenia, Marasmus, Pancytopenia, Pneumonia
Patient was taking Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: fungal infection (What is fungal infection?), haematotoxicity, infection susceptibility increased, leukopenia, marasmus, pancytopenia, pneumonia (What is pneumonia?) on Jul 20, 2009 from GERMANY Additional patient health information: Male patient , 69 years of age, weighting 183.9 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), immunosuppression, cardiac failure, cardiovascular event prophylaxis, osteoporosis (What is osteoporosis?) and. Alkeran dosage: 12.5mg Per Day. During the same period patient was treated with CELLCEPT (500mg Twice Per Day) (View Cellcept Review and Cellcept Label ), SANDIMMUNE (75mg Twice Per Day) (View Sandimmune Review and Sandimmune Label ), DEXAMETHASONE (40mg Four Times Per Day) (View Dexamethasone Review and Dexamethasone Label ), AQUAPHOR (20mg Per Day) (View Aquaphor Review and Aquaphor Label ), ASPIRIN (100mg Per Day) (View Aspirin Review and Aspirin Label ), SODIUM HYDROGEN CARBONATE (View Sodium Hydrogen Carbonate Review and Sodium Hydrogen Carbonate Label ), BLOPRESS (8mg Twice Per Day) (View Blopress Review and Blopress Label ), BONDRONAT (6mg Per Day) (View Bondronat Review and Bondronat Label ). Patient was hospitalized.

6279625-7 | Bone Sarcoma, Pain In Extremity
Adverse event was reported on Jul 13, 2009 by a Male patient taking Alkeran (View Usage) (Dosage: ) was diagnosed with medulloblastoma and. Location: JAPAN , child 11 years of age, Patient had the following side effects: bone sarcoma, pain in extremity. During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CAPREOMYCIN SULFATE (View Capreomycin Sulfate Review and Capreomycin Sulfate Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), THIOTEPA (View Thiotepa Review and Thiotepa Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CEFPIRAMIDE (View Cefpiramide Review and Cefpiramide Label ).

6265823-5 | Aplasia, Overdose, Pancytopenia, Thrombocytopenia
on Jul 02, 2009 Male patient from NETHERLANDS , weighting 110.2 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: aplasia, overdose, pancytopenia, thrombocytopenia. Alkeran dosage: 14mg Per Day. During the same period patient was treated with PREDNISOLONE (100mg Per Day) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6251368-5 | Alopecia, Aphthous Stomatitis, Fluid Intake Restriction, Lip Ulceration, Pancytopenia
on Jun 23, 2009 Female patient from JAPAN , weighting 17.86 lb, was diagnosed with retinoblastoma bilateral, prophylaxis of nausea and vomiting and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, aphthous stomatitis, fluid intake restriction, lip ulceration, pancytopenia. Alkeran dosage: . During the same period patient was treated with KYTRIL (.3mg Per Day) (View Kytril Review and Kytril Label ). Patient was hospitalized.

6239009-4 | Agranulocytosis, Cough, Pyrexia
Patient was taking Alkeran (View Usage). Patient had the following side effects: agranulocytosis, cough, pyrexia on Jun 10, 2009 from FRANCE Additional patient health information: Male patient , weighting 127.9 lb, was diagnosed with b-cell lymphoma and. Alkeran dosage: 230mg Single Dose. During the same period patient was treated with MABTHERA (630mg Single Dose) (View Mabthera Review and Mabthera Label ), BICNU (500mg Per Day) (View Bicnu Review and Bicnu Label ), ETOPOSIDE (670mg Per Day) (View Etoposide Review and Etoposide Label ), ARACYTINE (670mg Per Day) (View Aracytine Review and Aracytine Label ). Patient was hospitalized.

6194789-1 | Hepatotoxicity
Adverse event was reported on Apr 27, 2009 by a Male patient taking Alkeran (View Usage) (Dosage: 1 Mg/kg / Intravenous) was diagnosed with metastases to liver and. Location: NETHERLANDS , 69 years of age, After Alkeran was administered, patient had the following side effects: hepatotoxicity. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), HAEMACCEL (View Haemaccel Review and Haemaccel Label ).

6194786-6 | Hepatotoxicity
on Apr 27, 2009 Female patient from NETHERLANDS , 59 years of age, was diagnosed with metastases to liver and was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity. Alkeran dosage: 1 Mg/kg / Intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), HAEMACCEL (View Haemaccel Review and Haemaccel Label ).

6194779-9 | Hepatotoxicity
on Apr 27, 2009 Female patient from NETHERLANDS , 55 years of age, was diagnosed with metastases to liver and was treated with Alkeran (View Usage). Patient had the following side effects: hepatotoxicity. Alkeran dosage: 1 Mg/kg / Intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), HAEMACCEL (View Haemaccel Review and Haemaccel Label ).

6194777-5 | Hepatotoxicity
Patient was taking Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: hepatotoxicity on Apr 27, 2009 from NETHERLANDS Additional patient health information: Female patient , 56 years of age, was diagnosed with metastases to liver and. Alkeran dosage: 1 Mg/kg / Intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), HAEMACCEL (View Haemaccel Review and Haemaccel Label ).

6194774-X | Hepatotoxicity
Adverse event was reported on Apr 27, 2009 by a Female patient taking Alkeran (View Usage) (Dosage: 1 Mg/kg / Intravenous) was diagnosed with metastases to liver and. Location: NETHERLANDS , 60 years of age, Patient experienced the following unwanted or unexpected effects: hepatotoxicity. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), HAEMACCEL (View Haemaccel Review and Haemaccel Label ).

6194558-2 | Haematotoxicity, Hepatotoxicity, Pyrexia
on Apr 27, 2009 Female patient from NETHERLANDS , 49 years of age, was diagnosed with metastases to liver and was treated with Alkeran (View Usage). Patient had the following side effects: haematotoxicity, hepatotoxicity, pyrexia. Alkeran dosage: 1 Mg/kg/intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), HAEMACCEL (View Haemaccel Review and Haemaccel Label ).

6194557-0 | Haematotoxicity, Hepatotoxicity
on Apr 27, 2009 Female patient from NETHERLANDS , 68 years of age, was diagnosed with metastases to liver and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: haematotoxicity, hepatotoxicity. Alkeran dosage: 1 Mg/kg/intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), HAEMACCEL (View Haemaccel Review and Haemaccel Label ).

6194556-9 | Haematotoxicity, Hepatotoxicity, Malignant Neoplasm Progression, Metastatic Ocular Melanoma
Patient was taking Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: haematotoxicity, hepatotoxicity, malignant neoplasm progression, metastatic ocular melanoma on Apr 27, 2009 from NETHERLANDS Additional patient health information: Male patient , 57 years of age, was diagnosed with metastases to liver and. Alkeran dosage: 1 Mg/kg/intravenous. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), HAEMACCEL (View Haemaccel Review and Haemaccel Label ).

6173513-2 | Failure To Thrive, Mental Status Changes, Pyrexia, Renal Failure Acute
Adverse event was reported on Apr 22, 2009 by a Male patient taking Alkeran (View Usage) (Dosage: 10mg Per Day) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 71 years of age, Patient had the following side effects: failure to thrive, mental status changes, pyrexia, renal failure acute. During the same period patient was treated with THALIDOMIDE (200mg Per Day) (View Thalidomide Review and Thalidomide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ACTOS (View Actos Review and Actos Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6165284-0 | Haemorrhage Subcutaneous, Muscle Haemorrhage, Oedema Peripheral, Tenderness, Vasculitis
on Apr 16, 2009 Male patient from JAPAN , 13 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Alkeran (View Usage). After Alkeran was administered, patient had the following side effects: haemorrhage subcutaneous, muscle haemorrhage, oedema peripheral, tenderness, vasculitis (What is vasculitis?). Alkeran dosage: 140mgm2 Per Day. During the same period patient was treated with FRAGMIN (View Fragmin Review and Fragmin Label ), PROGRAF (View Prograf Review and Prograf Label ).

6161891-X | Pitting Oedema, Thrombosis
on Apr 10, 2009 Male patient from FRANCE , 79 years of age, was treated with Alkeran (View Usage). Patient experienced the following unwanted or unexpected effects: pitting oedema, thrombosis. Alkeran dosage: 12mg Per Day. During the same period patient was treated with THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), DEXAMETHASONE 4MG TAB (View Dexamethasone 4mg Tab Review and Dexamethasone 4mg Tab Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

6146495-7 | Cardiac Failure
Patient was taking Alkeran (View Usage). Patient had the following side effects: cardiac failure on Apr 03, 2009 from JAPAN Additional patient health information: Female patient , 75 years of age, . Alkeran dosage: .